LIDOCAINE ACCORD 1% lidocaine hydrochloride 20 mg/2 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine accord 1% lidocaine hydrochloride 20 mg/2 ml injection ampoule

accord healthcare pty ltd - lidocaine hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; sodium chloride; water for injections - lidocaine accord solutions are indicated for the production of local or regional anaesthesia by the following techniques: ? infiltration ? intravenous regional anaesthesia ? peripheral nerve block ? epidural block ? subarachnoid block

LIDOCAINE ACCORD 2% lidocaine hydrochloride 40 mg/2 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine accord 2% lidocaine hydrochloride 40 mg/2 ml injection ampoule

accord healthcare pty ltd - lidocaine hydrochloride, quantity: 40 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - lidocaine accord solutions are indicated for the production of local or regional anaesthesia by the following techniques: ? infiltration ? intravenous regional anaesthesia ? peripheral nerve block ? epidural block ? subarachnoid block

LIDOCAINE ACCORD 1% lidocaine hydrochloride 100 mg/10 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine accord 1% lidocaine hydrochloride 100 mg/10 ml injection ampoule

accord healthcare pty ltd - lidocaine hydrochloride, quantity: 100 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections; sodium chloride - lidocaine accord solutions are indicated for the production of local or regional anaesthesia by the following techniques: ? infiltration ? intravenous regional anaesthesia ? peripheral nerve block ? epidural block ? subarachnoid block

LIDOCAINE ACCORD 1% lidocaine hydrochloride 50 mg/5 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine accord 1% lidocaine hydrochloride 50 mg/5 ml injection ampoule

accord healthcare pty ltd - lidocaine hydrochloride, quantity: 50 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride; sodium hydroxide - lidocaine accord solutions are indicated for the production of local or regional anaesthesia by the following techniques: ? infiltration ? intravenous regional anaesthesia ? peripheral nerve block ? epidural block ? subarachnoid block

LIDOCAINE ACCORD 2% lidocaine hydrochloride 200 mg/10 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine accord 2% lidocaine hydrochloride 200 mg/10 ml injection ampoule

accord healthcare pty ltd - lidocaine hydrochloride, quantity: 200 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride - lidocaine accord solutions are indicated for the production of local or regional anaesthesia by the following techniques: ? infiltration ? intravenous regional anaesthesia ? peripheral nerve block ? epidural block ? subarachnoid block

LIDOCAINE ACCORD 2% lidocaine hydrochloride 400 mg/20 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine accord 2% lidocaine hydrochloride 400 mg/20 ml injection vial

accord healthcare pty ltd - lidocaine hydrochloride, quantity: 400 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride; hydrochloric acid - lidocaine accord solutions are indicated for the production of local or regional anaesthesia by the following techniques: ? infiltration ? intravenous regional anaesthesia ? peripheral nerve block ? epidural block ? subarachnoid block

LIDOCAINE ACCORD 2% lidocaine hydrochloride 100 mg/5 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine accord 2% lidocaine hydrochloride 100 mg/5 ml injection ampoule

accord healthcare pty ltd - lidocaine hydrochloride, quantity: 100 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - lidocaine accord solutions are indicated for the production of local or regional anaesthesia by the following techniques: ? infiltration ? intravenous regional anaesthesia ? peripheral nerve block ? epidural block ? subarachnoid block

TOPOTECAN ACCORD topotecan (as hydrochloride) 1 mg/1 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

topotecan accord topotecan (as hydrochloride) 1 mg/1 ml concentrated injection vial

accord healthcare pty ltd - topotecan hydrochloride, quantity: 1.09 mg (equivalent: topotecan, qty 1 mg) - injection, concentrated - excipient ingredients: tartaric acid; hydrochloric acid; sodium hydroxide; water for injections - topotecan accord is indicated as single agent therapy for the treatment of patients with:,? small cell lung carcinoma after failure of first line chemotherapy.,? metastatic carcinoma of the ovary after failure of first-line or subsequent therapy.,topotecan accord is indicated in combination with cisplatin for the treatment of patients with:,? histologically confirmed stage iv-b, recurrent, or persistent carcinoma of the cervix, which is not amenable to curative treatment with surgery and/or radiation therapy.

TOPOTECAN ACCORD topotecan (as hydrochloride) 4 mg/4 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

topotecan accord topotecan (as hydrochloride) 4 mg/4 ml concentrated injection vial

accord healthcare pty ltd - topotecan hydrochloride, quantity: 4.346 mg (equivalent: topotecan, qty 4 mg) - injection, concentrated - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections; tartaric acid - topotecan accord is indicated as single agent therapy for the treatment of patients with:,? small cell lung carcinoma after failure of first line chemotherapy.,? metastatic carcinoma of the ovary after failure of first-line or subsequent therapy.,topotecan accord is indicated in combination with cisplatin for the treatment of patients with:,? histologically confirmed stage iv-b, recurrent, or persistent carcinoma of the cervix, which is not amenable to curative treatment with surgery and/or radiation therapy.